Regent Surgical Health Closes Strategic Investment from TowerBrook Capital Partners L.P. and Ascension Capital

We represented Regent Surgical Health, an ambulatory surgery center management and development company, in its strategic investment from TowerBrook Capital Partners L.P., an international investment management firm, and Ascension Capital, an investment affiliate of Ascension. Terms of the transaction were not disclosed.

This transaction was named a finalist in the following categories for the 20th Annual M&A Advisor Awards in 2021:

  • Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Under $100MM)
  • M&A Transaction of the Year: Private Equity Deal of the Year ($75MM to $100MM)
  • M&A Transaction of the Year: M&A Deal of the Year ($75MM to $100MM)

Bass, Berry & Sims had seven separate deals recognized as finalists among 18 categories and was also named a finalist in the Law Firm of the Year category for the 2021 M&A Advisor Awards.

We represented Regent Surgical Health, an ambulatory surgery center management and development company, in its strategic investment from TowerBrook Capital Partners L.P., an international investment management firm, and Ascension Capital, an investment affiliate of Ascension. Terms of the transaction were not disclosed.

This transaction was named a finalist in the following categories for the 20th Annual M&A Advisor Awards in 2021:

  • Sector Deal of the Year: Healthcare/Life Sciences Deal of the Year (Under $100MM)
  • M&A Transaction of the Year: Private Equity Deal of the Year ($75MM to $100MM)
  • M&A Transaction of the Year: M&A Deal of the Year ($75MM to $100MM)

Bass, Berry & Sims had seven separate deals recognized as finalists among 18 categories and was also named a finalist in the Law Firm of the Year category for the 2021 M&A Advisor Awards.